Today's news report circulated by the media about the negative findings of a much touted, but uncontrolled observational study of depression (STAR*D) promotes the business interests of SSRI antidepressant drug manufacturers.
Conflicts of Interest Taint UK Gov panel investigating SSRI Wed, 19 Mar 2003 An article from the UK Guardian sheds light on how the credibility of an expert investigative government appointed committee is corrupted by financial conflicts of interest. Mounting complaints from . . . Continue reading →
Evidence of an association between violence and widely prescribed antidepressant drugs is the focus of this Infomail. Continue reading →
The law firm of Baum Hedlund filed a lawsuit against GlaxoSmithKline, the maker of the antidepressant, Paxil, for causing severe heart defects in the newborn son, of a woman prescribed Paxil during her pregnancy.
Continue reading →
Antidepressants involved in three suicides: 19-year old Chess Prodigy; 50-year old lawyer; 11-year old child Continue reading →
A provocative article by Dr. Joanna Moncrieff and Dr. David Cohen, PLOS Medicine, June 5. Continue reading →
An investigative report in The Hartford Courant will undoubtedly lead to a Congressional investigation.
The report reveals that mentally unstable soldiers are being deployed to the Iraq front in violation of federal law. Continue reading →
It is astonishing how untrustworthy loosely given advice about the safety of SSRI antidepressants by medical professionals and academic institutions. Continue reading →
Parents, physicians and the public attempting to make sense of the controversy about antidepressants are torn between unproven claims and counter-claims about the drugs’ benefits and risks.
Big Pharma by Jacky Law reveals that in essence, most of the pharmaceutical industry’s claims are false; it is not the drug, but the placebo effect whose potency deserves almost all of the credit for any health improvement:
Continue reading →